Overview

Investigation of Topical SB705498 on Healthy Volunteers

Status:
Completed
Trial end date:
2012-10-04
Target enrollment:
Participant gender:
Summary
A two part, randomized, double-blind, placebo controlled study to investigate the effects of topical doses of SB705498 in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Histamine